E
Mainz Biomed N.V. MYNZ
$4.40 -$0.33-6.98%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 12/23/2024Downgrade
Mainz Biomed N.V. (MYNZ) was downgraded to E+ from D- on 12/23/2024 due to a significant decline in the solvency index, total return index and volatility index. Debt to equity increased from 1.35 to 1.93.
D
Sell 6/2/2023Upgraded
Mainz Biomed N.V. (MYNZ) was upgraded to D- from E+ on 6/2/2023 due to an increase in the efficiency index and volatility index.
E
Sell 5/12/2023Downgrade
Mainz Biomed N.V. (MYNZ) was downgraded to E+ from D- on 5/12/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell 4/27/2023Upgraded
Mainz Biomed N.V. (MYNZ) was upgraded to D- from E+ on 4/27/2023 due to an increase in the volatility index and valuation index.
E
Sell 4/10/2023Downgrade
Mainz Biomed N.V. (MYNZ) was downgraded to E+ from D- on 4/10/2023 due to a noticeable decline in the solvency index, volatility index and growth index.
D
Sell 9/9/2022Upgraded
Mainz Biomed B.V. (MYNZ) was upgraded to D- from E+ on 9/9/2022 due to an increase in the solvency index, efficiency index and valuation index.
E
Sell 8/1/2022Upgraded
Mainz Biomed B.V. (MYNZ) was upgraded to E+ from E on 8/1/2022 due to an increase in the valuation index.
E
Sell 5/16/2022Upgraded
Mainz Biomed B.V. (MYNZ) was upgraded to E from E- on 5/16/2022 due to a significant increase in the solvency index, total return index and growth index.
E
Sell 2/1/2022None
Mainz Biomed N.V. (MYNZ) was downgraded to E- from U on 02/01/2022.
Weiss Ratings